Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Two supporting factors greatly improve the efficiency of human iPSC generation.

Zhao Y, Yin X, Qin H, Zhu F, Liu H, Yang W, Zhang Q, Xiang C, Hou P, Song Z, Liu Y, Yong J, Zhang P, Cai J, Liu M, Li H, Li Y, Qu X, Cui K, Zhang W, Xiang T, Wu Y, Zhao Y, Liu C, Yu C, Yuan K, Lou J, Ding M, Deng H.

Cell Stem Cell. 2008 Nov 6;3(5):475-9. doi: 10.1016/j.stem.2008.10.002. No abstract available.

2.

The first direct reprogramming of adult human fibroblasts.

Wilmut I.

Cell Stem Cell. 2007 Dec 13;1(6):593-4. doi: 10.1016/j.stem.2007.11.013. Review.

3.

Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.

Rony IK, Baten A, Bloomfield JA, Islam ME, Billah MM, Islam KD.

Cell Prolif. 2015 Apr;48(2):140-56. doi: 10.1111/cpr.12162. Epub 2015 Jan 29. Review.

PMID:
25643745
4.

Guidelines and techniques for the generation of induced pluripotent stem cells.

Maherali N, Hochedlinger K.

Cell Stem Cell. 2008 Dec 4;3(6):595-605. doi: 10.1016/j.stem.2008.11.008. Review.

5.

Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells.

Feng B, Ng JH, Heng JC, Ng HH.

Cell Stem Cell. 2009 Apr 3;4(4):301-12. doi: 10.1016/j.stem.2009.03.005. Review.

6.

X inactivation: a histone protects from reprogramming by the frog.

Wutz A.

EMBO J. 2011 Jun 15;30(12):2310-1. doi: 10.1038/emboj.2011.172. Review. No abstract available.

7.

Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies.

Lee AS, Tang C, Rao MS, Weissman IL, Wu JC.

Nat Med. 2013 Aug;19(8):998-1004. doi: 10.1038/nm.3267. Epub 2013 Aug 6. Review.

Supplemental Content

Support Center